Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 076549

Expand all

RAMIPRIL (RAMIPRIL)
1.25MG
Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: RAMIPRIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 1.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076549
Product Number: 001
Approval Date: Oct 24, 2005
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

RAMIPRIL (RAMIPRIL)
2.5MG
Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: RAMIPRIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076549
Product Number: 002
Approval Date: Oct 24, 2005
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

RAMIPRIL (RAMIPRIL)
10MG
Marketing Status: Prescription

Active Ingredient: RAMIPRIL
Proprietary Name: RAMIPRIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076549
Product Number: 004
Approval Date: Oct 24, 2005
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

RAMIPRIL (RAMIPRIL)
5MG
Marketing Status: Discontinued

Active Ingredient: RAMIPRIL
Proprietary Name: RAMIPRIL
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076549
Product Number: 003
Approval Date: Oct 24, 2005
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information